Analyst Consensus ?
ConsensusHold34 ratings
Bullish1852.9%
Neutral1441.2%
Bearish25.9%
Phillips 66 · PSX · FY2024 Q4 · Calendar Q1 2025
Phillips 66 leans on midstream growth amid refining pressure
The supplied analysis supports a measured positive view of Phillips 66's trajectory: midstream expansion, cost reductions and capital discipline provide potential support, but refining margins, shutdown impacts, leverage and chemicals recovery remain material constraints.
Reported Before market openNYSEEnergy
$113.54B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.23
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $34.64B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-2.5%
Event window
SPY move
-0.5%
Same window
Abnormal move
-1.9%
Stock minus SPY
Volume
2.6×
Versus trailing sessions
Subsequent drift
+6.0%
Up to 20 sessions
PSXSPY benchmark
Ask FN2 about PSX FY2024 Q4
Transcript, numbers and history already loaded
What drove PSX's -2.5% move after FY2024 Q4 earnings?What changed in PSX's guidance and outlook in FY2024 Q4?Give me the bull and bear case for PSX after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current analysis places greater emphasis on the EPIC acquisition and a larger midstream earnings contribution, while setting more explicit debt, refining-cost and mid-cycle EBITDA objectives. The Los Angeles shutdown, renewable-fuels credit uncertainty and chemicals-margin recovery remain central risks.
Guidance delta
Current analysis says guidance was maintained; the prior-quarter analysis did not provide guidance sentiment.
Key takeaways
- Midstream growth through EPIC, Pinnacle and organic projects is becoming a larger contributor.
- Refining cost reductions and clean-product yields helped offset weaker crack spreads and margins.
- Management paired growth plans with asset disposals, debt reduction and continued cash returns.
Management priorities
- Expand midstream and chemicals earnings through acquisitions and organic projects.
- Reduce debt toward the stated target while continuing asset disposals.
- Lower controllable refining costs and maintain disciplined capital allocation.
Follow PSX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$283.18Current
$48Low
$197.07Average
$345High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 13, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 12, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 12, 2026 |
| Mizuho | Neutral | Outperform | Downgrade | Oct 8, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 1, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 17, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Sep 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 14, 2026 |
| UBS | Buy | Buy | Maintain | Sep 8, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Sep 3, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 9, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Apr 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 13, 2026 |
| Freedom Capital Markets | Sell | Hold | Downgrade | Jan 6, 2026 |
| Freedom Broker | Sell | Hold | Downgrade | Jan 6, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Sep 3, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 3, 2025 |
| Argus Research | Buy | Buy | Maintain | May 30, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | May 4, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Dec 28, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | May 12, 2021 |
| CFRA | Buy | Buy | Maintain | Mar 20, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jan 7, 2020 |
| Macquarie | Outperform | Outperform | Maintain | Sep 5, 2019 |
| U.S. Capital Advisors | Buy | Overweight | Maintain | Nov 16, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 19, 2018 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Sep 28, 2017 |
| PiperJaffray | Neutral | Neutral | Maintain | Sep 16, 2016 |
| Oppenheimer | Outperform | Perform | Upgrade | May 27, 2015 |
| Gilford Securities | Neutral | Buy | Downgrade | Mar 31, 2015 |
| Tudor Pickering | Accumulate | Buy | Maintain | Apr 15, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $283.18. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $335 | $293.81 | +18.3% | Oct 19, 2026 |
| Wells Fargo | Sam Margolin | $345 | $292.73 | +21.8% | Oct 14, 2026 |
| Jefferies | Analyst unavailable | $276 | $278.18 | -2.5% | Oct 11, 2026 |
| Mizuho Securities | Nitin Kumar | $300 | $271.62 | +5.9% | Oct 8, 2026 |
| Goldman Sachs | Neil Mehta | $274 | $255.31 | -3.2% | Oct 1, 2026 |
| BMO Capital | Analyst unavailable | $310 | $264.63 | +9.5% | Sep 17, 2026 |
| Raymond James | Analyst unavailable | $300 | $261.61 | +5.9% | Sep 14, 2026 |
| Morgan Stanley | Analyst unavailable | $284 | $263.86 | +0.3% | Sep 14, 2026 |
| UBS | Manav Gupta | $300 | $255.09 | +5.9% | Sep 8, 2026 |
| Piper Sandler | Analyst unavailable | $264 | $256.09 | -6.8% | Sep 3, 2026 |
| Wells Fargo | Analyst unavailable | $335 | $246.58 | +18.3% | Sep 1, 2026 |
| Piper Sandler | John Royall | $209 | $203.91 | -26.2% | Aug 10, 2026 |
| Wells Fargo | Sam Margolin | $239 | $202.55 | -15.6% | Aug 6, 2026 |
| Barclays | Theresa Chen | $216 | $202.55 | -23.7% | Aug 6, 2026 |
| UBS | Manav Gupta | $235 | $205.78 | -17.0% | Jul 27, 2026 |
| Piper Sandler | Analyst unavailable | $208 | $211.41 | -26.5% | Jul 23, 2026 |
| Goldman Sachs | Neil Mehta | $235 | $212.27 | -17.0% | Jul 22, 2026 |
| Raymond James | Analyst unavailable | $235 | $194.4 | -17.0% | Jul 13, 2026 |
| Jefferies | Analyst unavailable | $207 | $189.64 | -26.9% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $183 | $188.68 | -35.4% | Jul 9, 2026 |
| UBS | Manav Gupta | $212 | $173.71 | -25.1% | Jun 15, 2026 |
| Morgan Stanley | Joe Laetsch | $196 | $178.1 | -30.8% | Jun 12, 2026 |
| Mizuho Securities | Nitin Kumar | $212 | $173.88 | -25.1% | May 27, 2026 |
| Goldman Sachs | Analyst unavailable | $207 | $182.38 | -26.9% | May 19, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $175.72 | -36.4% | Apr 30, 2026 |
| Morgan Stanley | Analyst unavailable | $174 | $159.53 | -38.6% | Apr 24, 2026 |
| Piper Sandler | Ryan Todd | $177 | $168 | -37.5% | Apr 8, 2026 |
| Barclays | Analyst unavailable | $158 | $155.41 | -44.2% | Feb 20, 2026 |
| Jefferies | Analyst unavailable | $158 | $155.41 | -44.2% | Feb 20, 2026 |
| UBS | Analyst unavailable | $172 | $158.31 | -39.3% | Feb 6, 2026 |
| BMO Capital | Phillip Jungwirth | $170 | $158.38 | -40.0% | Feb 6, 2026 |
| Morgan Stanley | Analyst unavailable | $147 | $154.69 | -48.1% | Feb 5, 2026 |
| Piper Sandler | Analyst unavailable | $156 | $154.69 | -44.9% | Feb 5, 2026 |
| Scotiabank | Paul Cheng | $140 | $140.08 | -50.6% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $152 | $138.8 | -46.3% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $142 | $142.16 | -49.9% | Jan 12, 2026 |
| Piper Sandler | Analyst unavailable | $153 | $142.16 | -46.0% | Jan 12, 2026 |
| Mizuho Securities | Analyst unavailable | $150 | $143.37 | -47.0% | Dec 12, 2025 |
| Piper Sandler | Analyst unavailable | $171 | $139.42 | -39.6% | Dec 5, 2025 |
| UBS | Manav Gupta | $160 | $138.4 | -43.5% | Nov 10, 2025 |
| Piper Sandler | Analyst unavailable | $159 | $138 | -43.9% | Oct 30, 2025 |
| Wells Fargo | Analyst unavailable | $162 | $138 | -42.8% | Oct 30, 2025 |
| Raymond James | Analyst unavailable | $150 | $129.13 | -47.0% | Oct 17, 2025 |
| Barclays | Analyst unavailable | $132 | $132.92 | -53.4% | Oct 7, 2025 |
| Morgan Stanley | Analyst unavailable | $140 | $134.94 | -50.6% | Oct 3, 2025 |
| Piper Sandler | Ryan Todd | $155 | $139.46 | -45.3% | Sep 29, 2025 |
| Raymond James | Analyst unavailable | $145 | $132.29 | -48.8% | Sep 9, 2025 |
| Morgan Stanley | Joe Laetsch | $128 | $127.51 | -54.8% | Jul 16, 2025 |
| Raymond James | Justin Jenkins | $142 | $129.01 | -49.9% | Jul 15, 2025 |
| Scotiabank | Paul Cheng | $133 | $131.71 | -53.0% | Jul 11, 2025 |
| Piper Sandler | Ryan Todd | $148 | $134.39 | -47.7% | Jul 10, 2025 |
| Cantor Fitzgerald | Matthew Prisco | $55 | $124.82 | -80.6% | Jun 18, 2025 |
| Goldman Sachs | Analyst unavailable | $132 | $124.72 | -53.4% | Mar 27, 2025 |
| Mizuho Securities | Nitin Kumar | $140 | $115.19 | -50.6% | Jan 13, 2025 |
| Barclays | Theresa Chen | $115 | $115.19 | -59.4% | Jan 13, 2025 |
| Piper Sandler | Ryan Todd | $144 | $132.31 | -49.1% | Oct 17, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $156 | $132.31 | -44.9% | Oct 17, 2024 |
| Mizuho Securities | Nitin Kumar | $160 | $135.85 | -43.5% | Jun 20, 2024 |
| Piper Sandler | Ryan Todd | $170 | $143.66 | -40.0% | May 14, 2024 |
| Mizuho Securities | Nitin Kumar | $162 | $165.41 | -42.8% | Apr 12, 2024 |
| Wells Fargo | Roger Read | $179 | $170.75 | -36.8% | Apr 8, 2024 |
| Piper Sandler | Ryan Todd | $187 | $170.68 | -34.0% | Apr 5, 2024 |
| Raymond James | Justin Jenkins | $140 | $133.21 | -50.6% | Jan 10, 2024 |
| RBC Capital | Analyst unavailable | $132 | $102.06 | -53.4% | Feb 8, 2023 |
| Raymond James | Analyst unavailable | $135 | $102.09 | -52.3% | Jan 13, 2023 |
| Wells Fargo | Analyst unavailable | $127 | $102.18 | -55.2% | Jan 5, 2023 |
| Piper Sandler | Analyst unavailable | $137 | $100.64 | -51.6% | Dec 19, 2022 |
| Raymond James | John Freeman | $48 | $102.07 | -83.0% | Dec 13, 2022 |
| RBC Capital | Analyst unavailable | $131 | $106.24 | -53.7% | Nov 10, 2022 |
| Goldman Sachs | Neil Mehta | $109 | $90.51 | -61.5% | Jun 21, 2022 |
| RBC Capital | Analyst unavailable | $106 | $89.94 | -62.6% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $114 | $86.76 | -59.7% | May 2, 2022 |
| Raymond James | Analyst unavailable | $107 | $86.76 | -62.2% | May 2, 2022 |
| Wells Fargo | Analyst unavailable | $103 | $88.87 | -63.6% | Apr 21, 2022 |
| Piper Sandler | Ryan Todd | $119 | $87.16 | -58.0% | Apr 18, 2022 |
| Cowen & Co. | Jason Gabelman | $78 | $73.15 | -72.5% | Dec 28, 2021 |
| Bank of America Securities | Doug Leggate | $102 | $80.95 | -64.0% | Oct 19, 2021 |
| Citigroup | Prashant Rao | $80 | $76.66 | -71.7% | Oct 6, 2021 |
| Credit Suisse | Manav Gupta | $95 | $81.54 | -66.5% | May 12, 2021 |
Track every rating change on PSX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPhillips 66 operates as a diversified energy company, specializing in both manufacturing and logistics. Its comprehensive business model is structured across four primary segments: Midstream, Chemicals, Refining, and Marketing & Specialties (M&S). The Midstream division manages the vital infrastructure for transporting and processing various energy commodities. This includes moving crude oil and other feedstocks, delivering refined petroleum products to market, offering terminaling and storage solutions, and handling natural gas liquids (NGLs) through processes like transportation, storage, fractionation, export, and marketing. It also provides fee-based processing services and oversees the gathering, processing, transportation, and marketing of natural gas. The Chemicals segment is dedicated to the production and distribution of a broad spectrum of chemical products.…
Historical context
All PSX earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SLB Slb N.V. | FY2026 Q3 · Calendar Q4 2026 | +3.7% | +7.1% | SLB Q3 2026: Growth Broadens Beyond Core Oilfield |
| E Eni S.p.A. | FY2026 Q3 · Calendar Q4 2026 | +13.9% | +4.3% | Eni pairs upstream growth with record shareholder returns and transition progress |
| VLO Valero Energy Corporation | FY2026 Q3 · Calendar Q4 2026 | +12.9% | -2.4% | Valero Q3: Record Profitability, Strong Cash Generation and Execution Risks |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the PSX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-17T00:04:44.363398+00:00
- Polygon adjusted daily market bars · 2026-10-25T07:30:43.945552+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-25T07:30:43.942666+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-25. For educational purposes only; not investment advice.